50 research outputs found
The effects of low and high glycemic index foods on exercise performance and beta-endorphin responses
Τhe aim of this study was to examine the effects of the consumption of foods of various glycemic index values on performance, β-endorphin levels and substrate (fat and carbohydrate) utilization during prolonged exercise. Eight untrained healthy males underwent, in a randomized counterbalanced design, three experimental conditions under which they received carbohydrates (1.5 gr. kg-1 of body weight) of low glycemic index (LGI), high glycemic index (HGI) or placebo. Food was administered 30 min prior to exercise. Subjects cycled for 60 min at an intensity corresponding to 65% of VO2max, which was increased to 90% of VO2max, then they cycled until exhaustion and the time to exhaustion was recorded. Blood was collected prior to food consumption, 15 min prior to exercise, 0, 20, 40, and 60 min into exercise as well as at exhaustion. Blood was analyzed for β-endorphin, glucose, insulin, and lactate. The mean time to exhaustion did not differ between the three conditions (LGI = 3.2 ± 0.9 min; HGI = 2.9 ± 0.9 min; placebo = 2.7 ± 0.7 min). There was a significant interaction in glucose and insulin response (P < 0.05) with HGI exhibiting higher values before exercise. β-endorphin increased significantly (P < 0.05) at the end of exercise without, however, a significant interaction between the three conditions. Rate of perceived exertion, heart rate, ventilation, lactate, respiratory quotient and substrate oxidation rate did not differ between the three conditions. The present study indicates that ingestion of foods of different glycemic index 30 min prior to one hour cycling exercise does not result in significant changes in exercise performance, β-endorphin levels as well as carbohydrate and fat oxidation during exercise
What the radiologist needs to know about the diabetic patient
Diabetes mellitus (DM) is recognised as a major health problem. Ninety-nine percent of diabetics suffer from type 2 DM and 10% from type 1 and other types of DM. The number of diabetic patients worldwide is expected to reach 380 millions over the next 15 years. The duration of diabetes is an important factor in the pathogenesis of complications, but other factors frequently coexisting with type 2 DM, such as hypertension, obesity and dyslipidaemia, also contribute to the development of diabetic angiopathy. Microvascular complications include retinopathy, nephropathy and neuropathy. Macroangiopathy mainly affects coronary arteries, carotid arteries and arteries of the lower extremities. Eighty percent of deaths in the diabetic population result from cardiovascular incidents. DM is considered an equivalent of coronary heart disease (CHD). Stroke and peripheral artery disease (PAD) are other main manifestations of diabetic macroangiopathy. Diabetic cardiomyopathy (DC) represents another chronic complication that occurs independently of CHD and hypertension. The greater susceptibility of diabetic patients to infections completes the spectrum of the main consequences of DM. The serious complications of DM make it essential for physicians to be aware of the screening guidelines, allowing for earlier patient diagnosis and treatment
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes?:Systematic review
background: It is unclear whether more timely cancer diagnosis brings favourable outcomes, with much of the previous evidence, in some cancers, being equivocal. We set out to determine whether there is an association between time to diagnosis, treatment and clinical outcomes, across all cancers for symptomatic presentations. methods: Systematic review of the literature and narrative synthesis. results: We included 177 articles reporting 209 studies. These studies varied in study design, the time intervals assessed and the outcomes reported. Study quality was variable, with a small number of higher-quality studies. Heterogeneity precluded definitive findings. The cancers with more reports of an association between shorter times to diagnosis and more favourable outcomes were breast, colorectal, head and neck, testicular and melanoma. conclusions: This is the first review encompassing many cancer types, and we have demonstrated those cancers in which more evidence of an association between shorter times to diagnosis and more favourable outcomes exists, and where it is lacking. We believe that it is reasonable to assume that efforts to expedite the diagnosis of symptomatic cancer are likely to have benefits for patients in terms of improved survival, earlier-stage diagnosis and improved quality of life, although these benefits vary between cancers
Laparoscopy in management of appendicitis in high-, middle-, and low-income countries: a multicenter, prospective, cohort study.
BACKGROUND: Appendicitis is the most common abdominal surgical emergency worldwide. Differences between high- and low-income settings in the availability of laparoscopic appendectomy, alternative management choices, and outcomes are poorly described. The aim was to identify variation in surgical management and outcomes of appendicitis within low-, middle-, and high-Human Development Index (HDI) countries worldwide. METHODS: This is a multicenter, international prospective cohort study. Consecutive sampling of patients undergoing emergency appendectomy over 6 months was conducted. Follow-up lasted 30 days. RESULTS: 4546 patients from 52 countries underwent appendectomy (2499 high-, 1540 middle-, and 507 low-HDI groups). Surgical site infection (SSI) rates were higher in low-HDI (OR 2.57, 95% CI 1.33-4.99, p = 0.005) but not middle-HDI countries (OR 1.38, 95% CI 0.76-2.52, p = 0.291), compared with high-HDI countries after adjustment. A laparoscopic approach was common in high-HDI countries (1693/2499, 67.7%), but infrequent in low-HDI (41/507, 8.1%) and middle-HDI (132/1540, 8.6%) groups. After accounting for case-mix, laparoscopy was still associated with fewer overall complications (OR 0.55, 95% CI 0.42-0.71, p < 0.001) and SSIs (OR 0.22, 95% CI 0.14-0.33, p < 0.001). In propensity-score matched groups within low-/middle-HDI countries, laparoscopy was still associated with fewer overall complications (OR 0.23 95% CI 0.11-0.44) and SSI (OR 0.21 95% CI 0.09-0.45). CONCLUSION: A laparoscopic approach is associated with better outcomes and availability appears to differ by country HDI. Despite the profound clinical, operational, and financial barriers to its widespread introduction, laparoscopy could significantly improve outcomes for patients in low-resource environments. TRIAL REGISTRATION: NCT02179112
Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy
Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet its place in emergency surgery has not been assessed on a global scale. The aim of this study was to evaluate reported checklist use in emergency settings and examine the relationship with perioperative mortality in patients who had emergency laparotomy. Methods In two multinational cohort studies, adults undergoing emergency laparotomy were compared with those having elective gastrointestinal surgery. Relationships between reported checklist use and mortality were determined using multivariable logistic regression and bootstrapped simulation. Results Of 12 296 patients included from 76 countries, 4843 underwent emergency laparotomy. After adjusting for patient and disease factors, checklist use before emergency laparotomy was more common in countries with a high Human Development Index (HDI) (2455 of 2741, 89.6 per cent) compared with that in countries with a middle (753 of 1242, 60.6 per cent; odds ratio (OR) 0.17, 95 per cent c.i. 0.14 to 0.21, P <0001) or low (363 of 860, 422 per cent; OR 008, 007 to 010, P <0.001) HDI. Checklist use was less common in elective surgery than for emergency laparotomy in high-HDI countries (risk difference -94 (95 per cent c.i. -11.9 to -6.9) per cent; P <0001), but the relationship was reversed in low-HDI countries (+121 (+7.0 to +173) per cent; P <0001). In multivariable models, checklist use was associated with a lower 30-day perioperative mortality (OR 0.60, 0.50 to 073; P <0.001). The greatest absolute benefit was seen for emergency surgery in low- and middle-HDI countries. Conclusion Checklist use in emergency laparotomy was associated with a significantly lower perioperative mortality rate. Checklist use in low-HDI countries was half that in high-HDI countries.Peer reviewe
Global variation in anastomosis and end colostomy formation following left-sided colorectal resection
Background
End colostomy rates following colorectal resection vary across institutions in high-income settings, being influenced by patient, disease, surgeon and system factors. This study aimed to assess global variation in end colostomy rates after left-sided colorectal resection.
Methods
This study comprised an analysis of GlobalSurg-1 and -2 international, prospective, observational cohort studies (2014, 2016), including consecutive adult patients undergoing elective or emergency left-sided colorectal resection within discrete 2-week windows. Countries were grouped into high-, middle- and low-income tertiles according to the United Nations Human Development Index (HDI). Factors associated with colostomy formation versus primary anastomosis were explored using a multilevel, multivariable logistic regression model.
Results
In total, 1635 patients from 242 hospitals in 57 countries undergoing left-sided colorectal resection were included: 113 (6·9 per cent) from low-HDI, 254 (15·5 per cent) from middle-HDI and 1268 (77·6 per cent) from high-HDI countries. There was a higher proportion of patients with perforated disease (57·5, 40·9 and 35·4 per cent; P < 0·001) and subsequent use of end colostomy (52·2, 24·8 and 18·9 per cent; P < 0·001) in low- compared with middle- and high-HDI settings. The association with colostomy use in low-HDI settings persisted (odds ratio (OR) 3·20, 95 per cent c.i. 1·35 to 7·57; P = 0·008) after risk adjustment for malignant disease (OR 2·34, 1·65 to 3·32; P < 0·001), emergency surgery (OR 4·08, 2·73 to 6·10; P < 0·001), time to operation at least 48 h (OR 1·99, 1·28 to 3·09; P = 0·002) and disease perforation (OR 4·00, 2·81 to 5·69; P < 0·001).
Conclusion
Global differences existed in the proportion of patients receiving end stomas after left-sided colorectal resection based on income, which went beyond case mix alone
Pathogenesis of diabetic nephropathy
Diabetic Nephropathy (DN) is the commonest cause of end-stage renal
failure (ESRF) in the Western world. Diabetic nephropathy follows a well
outline clinical course, starting with microalbuminuria, there are
various renal functional changes through proteinuria, azotaemia and
culminating in ESRF Before the onset of overt proteinuria, there are
various renal functional changes including renal hyperfiltration,
hyperperfusion, and increasing capillary permeability to macromolecules.
Basement-membrane thickening and mesangial expansion have long been
recognized as pathological hallmark of diabetes. Tr has been postulated
that DN occurs as a result of the interplay of metabolic and hemodynamic
factors in the renal microcirculation. There is no doubt that there is a
positive relationship between hyperglycaemia, which is necessary but not
sufficient, and microvascular complications. The accumulation of
advanced glycosylated end-products (AGEs), the activation of isoform(s)
of protein kinase C (PKC) and the acceleration of the aldose reductase
pathway may explain how hyper glycemia damages tissue. PKC is one of the
key signaling molecules in the induction of the vascular pathology of
diabetes. The balance between extracellular matrix production and
degradation is important in this context. Transforming growth
factor-beta a (TGF-beta) appears to play a pivotal role in accumulation
in the diabetic kidney. Hemodynamic disturbances are believed to be
directly responsible for the development of glomerulosclerosis and its
attendant proteinuria. There is familial clustering of diabetic
development of glomeruloscIerosis and its attendant kidney disease. A
number of gene loci have been investigated to try to explain the genetic
susceptibility to diabetic nephropathy. The genes coding for components
of renin-angiotensin system have drawn special attention, due to the
central role that this system plays in the regulation of blood pressure,
sodium metabolism, and renal hemodynamics. Endothelial dysfunction is
closely associated with the development of diabetic retinopathy,
nephropathy and atherosclerosis, both in IDDM and in NIDDM. The
pathogenesis of diabetic nephropathy is not clarified completely yet
Diabetes and premature menopause: is their co-existence detrimental to the skeleton?
Objective: Premature menopause is a known risk factor for osteoporosis,
whilst the influence of type 2 diabetes on bone mineral density (BMD) is
still controversial.
Design and methods: BMD values assessed by dual-energy X-ray
absorptiometry (DXA) in L2-L4 vertebrae and the femoral neck (FN) of 40
diabetic women with premature menopause (D-EMP) were compared with those
of 60 non-diabetic, prematurely menopausal women (EMP) and 60 diabetic
women with normal menopause (D-NMP) who had been matched by age and body
mass index (BMI). In all women, the time elapsed since menopause ranged
between 10 and 25 years and the duration of diabetes exceeded 75%, of
the postmenopausal time period. The age of D-EMP women was 58.7 +/- 5
years (mean +/- 1 S.D.), age at menopause 39.5 +/- 2.7, years since
menopause 18.6 +/- 4.9, BMI 27.8 +/- 4.3 kg/m(2) and duration of
diabetes 13.9 +/- 3.9 years.
Results: Vertebral BMD values of D-EMP women were significantly higher
than those of EMP women (0.908 +/- 0.135 vs. 0.817 +/- 0.14 g/cm(2), p =
0. 002), although there was no significant difference between D-EMP and
D-NMP women (0.886 +/- 0.15 g/cm(2)). No significant differences were
observed in FN BUD values between all groups. Age-adjusted BMD values (Z
scores) of D-EMP women were higher than EMP women in both anatomic sites
(P < 0.01), but did not differ from D-NMP women. In contrast to the
other two groups, no statistically significant correlation was observed
in D-EMP women between the BMD values of either anatomic area and the
time elapsed since menopause. HbA(1c) values were positively correlated
only to vertebral BMD values of the D-EMP group (P < 0.05). No
correlation was observed between the BMD values and the duration of
diabetes either in D-EMP or in D-NMP women.
Conclusions: Type 2 diabetes seems to positively affect the mineral
density of the trabecular bone in women with premature menopause. The
duration or diabetes does not appear to influence bone mass
Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-Miglitol) in insulin-treated Type 2 diabetes mellitus
In a double-blind, randomized study, miglitol (BAY m 1099), an
alpha-glucosidase inhibitor, 100 mg tds or placebo was given orally with
meals for a period of 24 weeks in 117 patients with Type 2
(non-insulin-dependent) diabetes mellitus (DM) treated with insulin.
Easting and 1 h postprandial plasma glucose and C-peptide were measured
at the beginning and at the end of each 4-week interval and glycosylated
haemoglobin was determined at day 0 and at the end of the 12th and 24th
week. One hour postprandial plasma glucose was significantly lower in
the miglitol group at the end of the 24th week (placebo: 11.6 +/- 1.5 vs
miglitol: 8.2 +/- 1.5 mmol l(-1), mean +/- SD, p = 0.001). Diabetes
control improved in the same group as the HbA(1) was lowered by 16 % (p
= <0.0001) at the end of the treatment. Mild reversible adverse effects
were observed in 37 patients of the miglitol group (mainly flatulence
and mild hypoglycaemia) and 2 of the placebo group. Urinary glucose was
rendered negative in 41 patients in the miglitol group only. Thus
miglitol appears to be a safe and effective adjunct in the management of
Type 2 DM, in association with insulin. (C) 1998 John Wiley & Sons,
Ltd
Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man
A single-center, randomised, placebo- controlled, crossover study was
conducted to characterize the new sulfonylurea glimepiride and to
compare its profile of action with the second generation sulfonylurea
glibenclamide.
The total duration of each experiment was 5 hours. At zero time an i.v.
injection of 2 and 4 mg glimepiride, 1 mg glibenclamide or placebo was
given IV to 24 healthy volunteers. Blood samples were collected for
three hours after the injection (0-3 hours, preprandial experiment). At
3 hours, a standard mixed meal was given (20% of a 30 Kcal/Kg Body
Weight diet) and blood samples were collected for 2 more hours
(postprandial experiment).
Pre-prandially (0-3 hrs) blood glucose (expressed as the area under the
curve divided by the time) was significantly lower (p < 0.0001) after
the administration of 2 and 4 mg glimepiride (3.8 +/- 0.22 and 3.5 +/-
10.3 mM respectively) compared to placebo (4.63 +/- 0.31 mM), but not
compared to glibenclamide. Insulin and C-peptide were not different
after glimepiride or glibenclamide. Both glimepiride and glibenclamide
had similar effects on insulin secretion. Post-prandially (3-5 hrs)
blood glucose was significantly higher after glibenclamide (6.54 +/- 0.8
mM) (p < 0.0001) than after 2 mg glimepiride (5.75 +/- 0.5 mM). Despite
this C-peptide was significantly higher (p < 0.002) glibendamide (5.7
+/- 1.5 ng/ml) compared to glimepiride (5.1 +/- 1.3 ng/ml); the trend
was the same for insulin but the results were not significantly
different (p = 0.06)
In conclusion, in the fasting state, glimepiride and glibenclamide had
similar effects on the changes in blood glucose levels after TV
administration. After the meal, less pronounced hyperglycemia and lower
insulin and C-peptide levels following glimepiride (2 mg) suggests
either that glimepiride induces insulin secretion through a pathway
which is different from that of glibenclamide or that glimepiride
facilitates insulin action through extrapancreatic effects